wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37468293-85C397D2-7B96-4429-8CE7-91F8D08E4EF2
Q37468293-85C397D2-7B96-4429-8CE7-91F8D08E4EF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37468293-85C397D2-7B96-4429-8CE7-91F8D08E4EF2
Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases.
P2860
Q37468293-85C397D2-7B96-4429-8CE7-91F8D08E4EF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37468293-85C397D2-7B96-4429-8CE7-91F8D08E4EF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e69478aee876af5b6e1552d7603551ab72c1cca6
P2860
A Phase I Clinical Trial of CHT-25 a 131I-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma.